240
Right out of the gate, this revenue generating licensed producer that has been a regular fixture in CannaInvestor Magazine’s content and stock lists has no USA assets per this news release.
In May, Harvest One (“HVST”) was on our Stocks to Watch list and by last issue had migrated to the Top Stock Picks list (proprietary metrics). Their wholly owned LP (United Greeneries Ltd)
received their sales license in October. HVST was part of our June case study titled “New Kids on The Block”.
For those interested in the history of HVST (and how it came to own two former holdings of MMJ Phytotech Ltd) please refer to their website. HVST describes the company as having a dual strategy – medical cannabis and recreational cannabis through their two aforementioned wholly owned subsidaries United Greeneries Ltd (the LP) and Satipharm AG.
According to their website, “Satapharm is specialized in the development and manufacturing of cannabis-based health products and is Harvest One’s medical and health brand. Satipharm’s goal is to develop cutting-edge technology and pharmaceutical-grade cannabis products for the medical and health-based cannabis markets”.
We’ve seen reports recently of delays in granting licenses for cultivation in Germany which has seemingly dragged on amidst significant shortage in supply on legal cannabis, however German authorities recently granted Satipharm a “Free Sale Certificate” that confirms that their capsules can be sold as a food supplement and therefore removes trading impediments in other EU countries.
Since then, the company has seen its distribution network rise rapidly, focusing on larger European markets (Germany, Denmark, UK, Ireland, Netherlands, Spain and Austria), as
well as online, including Amazon. As a result sales of their CBD capsules are expected to reach $180,000 in Q1 2018. A patent application
for its Gelpell-CBD technology has been received and once granted will be owned by Satipharm and its manufacturing partner GelPell AG and covers the cannabis-derived perscription drugs developed by PhytoTech Therapuetics, wholly owned by MMJ Phytotech (who owns around 59% of Harvest One).
HARVEST ONE CANNABIS INC
TSXV:HVST
As At Date 11/29/2017
Shares Outstanding: 89,177,458 (www.tmxmoney.com)
Share Price: $0.88 Market Cap: $78,476,163
By Spiro Sertsis